Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro]
RxNorm 2048015
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2048015 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro]
(Atom ID: 12316101)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Atropine / hyoscyamine / PHENobarbital / scopolamine Oral Solution [Phenohytro]
(Atom ID: 12378894)
Patient Education
Belladonna Alkaloid Combinations and Phenobarbital
Belladonna alkaloid combinations and phenobarbital are used to relieve cramping pains in conditions such as irritable bowel syndrome and spastic colon. They also are used with other medicine to treat ulcers. These medicines decrease the motion of the stomach and intestines and the secretion of stomach fluids, including acid. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.